UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report: November 16, 2016
(Date of earliest event reported)
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
| Nevada | 1-7293 | 95-2557091 | ||
(State of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
1445 Ross Avenue, Suite 1400
Dallas, Texas 75202
(Address of principal executive offices, including zip code)
(469)893-2200
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 7.01 | Regulation FD Disclosure |
On November 16, 2016, Tenet Healthcare Corporation issued a press release announcing the pricing of the previously announced private placement offering of $750 million in aggregate principal amount of senior secured second lien notes due 2022, which represented an increase in the total aggregate principal amount from $500 million to $750 million. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
| (a) | The following exhibits are filed as a part of this Report. |
Exhibit No. | Description | |
| 99.1 | Press release issued on November 16, 2016 announcing pricing of private placement offering | |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TENET HEALTHCARE CORPORATION | ||||||
| Date: November 16, 2016 | ||||||
| By: | /s/ Paul A. Castanon | |||||
| Name: | Paul A. Castanon | |||||
| Title: | Vice President, Deputy General Counsel and Corporation Secretary | |||||
EXHIBIT INDEX
Exhibit No. | Description | |
| 99.1 | Press release issued on November 16, 2016 announcing pricing of private placement offering | |